Other Clinical Trial - Penpulimab Combined With Chemotherapy for

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05094804` - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents	Phase 1/Phase 2
Recruiting	`NCT03317327` - REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors	Phase 1/Phase 2
Terminated	`NCT02892201` - Pembrolizumab in HNSCC With Residual Disease After Radiation	Phase 2
Active, not recruiting	`NCT04854499` - Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma	Phase 2
Terminated	`NCT04110249` - Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer	N/A
Terminated	`NCT02495896` - Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors	Phase 1
Recruiting	`NCT05107674` - A Study of NX-1607 in Adults With Advanced Malignancies	Phase 1
Recruiting	`NCT05338905` - Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial	N/A
Recruiting	`NCT04045496` - A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors	Phase 1
Completed	`NCT04452214` - A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors	Phase 1
Recruiting	`NCT04096638` - Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors	Phase 1
Active, not recruiting	`NCT03070366` - Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC	Phase 2
Not yet recruiting	`NCT06289049` - Heavy Strength Training in Head and Neck Cancer Survivors	Phase 2
Recruiting	`NCT02661152` - DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.	Phase 3
Terminated	`NCT02488629` - Study of SCB01A in Patient With Head and Neck Cancer	Phase 2
Completed	`NCT01697800` - A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract	Phase 2
Completed	`NCT01427478` - Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck	Phase 3
Recruiting	`NCT05437380` - Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC	N/A
Recruiting	`NCT05065086` - Single Modality Trans Oral Robotic Surgery for Primary Oropharyngeal Cancer: Exploring the Impact of Surgical Margins on Local Disease Recurrence
Completed	`NCT03022409` - A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).	Phase 1

NCT number	NCT06081673
Study type	Interventional
Source	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Contact	Min Ruan, PhD
Phone	18019790370
Email	doctorruanmin@situ.edu.cn
Status	Recruiting
Phase	Phase 2
Start date	October 30, 2023
Completion date	October 30, 2026

Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms